Radiobiological concepts for treatment planning of schemes that combines external beam radiotherapy and systemic targeted radiotherapy (CIERT) Carlos Calderón.

Slides:



Advertisements
Similar presentations
Edited version of presentation given at RSNA
Advertisements

بسم الله الرحمن الرحيم ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Harvard Medical School Massachusetts General Hospital.
Pulmonary Stereotactic Ablative Radiotherapy:
Esteban Fabián Boggio 1 Lucas Provenzano 2 Sara Gonzalez 2,3 Sara Gonzalez 2,3 Juan Manuel Longhino 1 1 Bariloche Atomic Center, Atomic Energy National.
Multi-tracer analysis for patient’s following using multi-observation statistical image fusion : a feasibility study S. David 1, M. Hatt 1, P. Fernandez.
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature 5/15/2009.
Physical optimization criteria Target objective function N t = number of voxels in target D i = dose to voxel i D presc = prescribed dose to target D min.
What is radiation therapy (RT)? Cancer treatment Tumor versus normal tissues External photon beam RT.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Introduction Modern radiation therapies such as intensity-modulated radiation therapy (IMRT) and volume modulated arc therapy (VMAT) demand from dose calculation.
Clinical application of TCP ・ NTCP. Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat Res Suppl 1985; 8:S13–S19. Because.
Radioisotopes in Medicine
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
Introduction to Nuclear Medicine
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
Molecular Biomarkers in Radiotherapy of Cervical Cancer A collaboration project between Department of Gynecologic Oncology and Department of Radiation.
Prediction of Regional Tumor Spread Using Markov Models Megan S. Blackburn Monday, April 14, 2008.
Challenges for TPS Chunhua Men Elekta Software, Treatment Planning System BIRS Workshop Banff, Canada 3/12/2011.
The external beam radiotherapy and Image-guided radiotherapy (2)
Data Mining to Aid Beam Angle Selection for IMRT Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil- American University.
Parameter selection in prostate IMRT Renzhi Lu, Richard J. Radke 1, Andrew Jackson 2 Rensselaer Polytechnic Institute 1,Memorial Sloan-Kettering Cancer.
Predictive models validated by clinical data: new strategies for fractionation Dr. M. Benassi Dr. S. Marzi.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
1 GEANT4: Applications in Medical Physics B. Caccia Department of Technology and Health Istituto Superiore di Sanità (Italian National Institute of Health)
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
THE DATA EXPLOSION: HOW CAN WE ACHIEVE INTEROPERABILITY F.David Rollo M.D., PhD., FACC, FACNP Chief Medical Officer Philips Medical Systems.
Dose-Volume Based Ranking of Incident Beams and its Utility in Facilitating IMRT Beam Placement Jenny Hai, PhD. Department of Radiation Oncology Stanford.
Institute for Advanced Radiation Oncology
N.B. for a given fraction size
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
Permanent Interstitial Implants Ideal strategy to curatively manage small volume gynecologic malignancies Can deliver high cumulative radiation dose to.
Laurie Cuttino MD, Dorin Todor PhD, Douglas Arthur MD, Rohini George, Lynn Pacyna CMD Medical College of Virginia Campus Department of Radiation Oncology.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Principles of Radiation Oncology in (advanced stage) NSCLC
F. Foppiano, M.G. Pia, M. Piergentili
Somvilai Mayurasakorn, MD. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang Mai University Somvilai Mayurasakorn, MD. Division.
8/Mar./041st Workshopon the Italy-Japan Collaboration on Geant4 Medical Application 1 Use-Case on treatment planning at HIMAC Koichi Murakami KEK 1 st.
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Flair development for the MC TPS Wioletta Kozłowska CERN / Medical University of Vienna.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Dae-Hyun Kim Dept. of Biomedical Engineering The Catholic University of Korea Department of Biomedical Engineering Research Institute.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
UNIVERSAL SURVIVAL CURVE AND SINGLE FRACTION EQUIVALENT DOSE: USEFUL TOOLS IN UNDERSTANDING POTENCY OF ABLATIVE RADIOTHERAPY CLINT PARK, M.D. M.S., LECH.
The Effects of Small Field Dosimetry on the Biological Models Used In Evaluating IMRT Dose Distributions Gene Cardarelli,PhD, MPH.
MCS overview in radiation therapy
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
"Approaches on the role of medical physicists in implementing the hybrid technologies in Nuclear Medicine". Papel de la FM en la implementación de los.
cyberknife®: can we cure pancreatic cancer?
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Quantitative Nuclear Medicine Imaging
International Workshop on radiosensitization
Development and characterization of the Detectorized Phantom for research in the field of spatial fractionated radiation therapy. D. Ramazanov, V. Pugatch,
A Brachytherapy Treatment Planning Software Based on Monte Carlo Simulations and Artificial Neural Network Algorithm Amir Moghadam.
Radioisotopes in Medicine
Clinical Radiation Oncology NMT232 L 10
Geant4 at IST Applications in Brachytherapy
Neoadjuvant Adjuvant Curative Palliative
Sheng Yang a, Yen-Wan Hsueh Liu b
Nanoparticles for enhancing the effectiveness of proton therapy
GHG meeting at ESTRO36 May, 2017
Presentation transcript:

Radiobiological concepts for treatment planning of schemes that combines external beam radiotherapy and systemic targeted radiotherapy (CIERT) Carlos Calderón Marín, M.Sc. Nuclear Medicine Dept. Oncology and Radiobiology Institute, Havaba, Cuba Physics and Applications of High Brightness Beams March 28-April 1, 2016 in Havana, Cuba

Our previous experiences and conditions Experiences performing 2D and 3D internal dose estimations using NM imaging Experiences performing 2D and 3D internal dose estimations using NM imaging Projects for the development of methods for treatment planning in targeted systemic radiotherapy (  emitters mainly) Projects for the development of methods for treatment planning in targeted systemic radiotherapy (  emitters mainly) Availability of medical imaging systems (SPECT, SPECT/CT and PET/CT) Availability of medical imaging systems (SPECT, SPECT/CT and PET/CT) Availability of therapeutic radiopharmaceuticals and treatment systems for external beam radiotherapy (linacs, brachytherapy, IORT ) Availability of therapeutic radiopharmaceuticals and treatment systems for external beam radiotherapy (linacs, brachytherapy, IORT ) Radiobiology modeling for treatment planning and evaluation of prescriptions. A long way to run yet! Radiobiology modeling for treatment planning and evaluation of prescriptions. A long way to run yet! Calderón CF | ICFA workshop | Habana, 2016

Combined Radiotherapy (CIERT) Calderón CF | ICFA workshop | Habana, 2016 Basics! The combination of different therapy modalities for cancer treatment have been often used in order to enhance the outcomes The combination of different therapy modalities for cancer treatment have been often used in order to enhance the outcomes CIERT = Combining Internal (sMRT) and External (eLRT) Radiotherapy CIERT = Combining Internal (sMRT) and External (eLRT) Radiotherapy CIERT could be an alternative: CIERT could be an alternative: – in those patients with multiple lesions, or – when the constrains for OARs will difficult the planning, or – to increase dose in tumor without overlapping toxicity Since the dose rate are different it should be taken into account calculations! Since the dose rate are different it should be taken into account calculations!

Combined Radiotherapy (CIERT) Pre-clinical CIERT studies have been conducted for more than 25 years, but published outcomes are difficult to compare: Pre-clinical CIERT studies have been conducted for more than 25 years, but published outcomes are difficult to compare: – Different tumors and target entities, – Different radiopharmaceuticals (carriers + radionuclides – Different treatment schedules – Clarity of endpoints Few clinical researches, but the experiences have confirmed that it is a promising approach! Few clinical researches, but the experiences have confirmed that it is a promising approach! Systemic Radiotherapy branch Both branchs Calderón CF | ICFA workshop | Habana, 2016 Basics!

Combined Radiotherapy (CIERT) Calderón CF | ICFA workshop | Habana, 2016 OARs CIERT = OARs eLRT + OARs sMRT OARs CIERT = OARs eLRT + OARs sMRT  eLRT: depends of anatomical region and the treatment plan  sMRT: Highly dependent of the RF type and organs uptake  OARs eLRT ≠ OARs sMRT PTV: PTV:  eLRT: depends of anatomical region  sMRT: heterogeneous dose distribution (spatial and temporal). Highly dependent of the RF type and tumor uptake Basics!

Combined Radiotherapy (CIERT) SOME PROBLEMS, BUT NOT THE UNIQUES! The most of studies only reports TCP from 3D dose distribution in tumors The most of studies only reports TCP from 3D dose distribution in tumors The acceptance criteria of treatment prescriptions are based on the maximum tolerable dose in OAR instead NTCP The acceptance criteria of treatment prescriptions are based on the maximum tolerable dose in OAR instead NTCP There are not protocols for patient- specific 3D internal dose estimations of dose distribution in normal tissues There are not protocols for patient- specific 3D internal dose estimations of dose distribution in normal tissues Lack of radiobiological parameters Lack of radiobiological parameters Calderón CF | ICFA workshop | Habana, 2016 Systemic Radiotherapy branch Radiobiology

Combined Radiotherapy (CIERT) Calderón CF | ICFA workshop | Habana, 2016 INTERNAL DOSE ESTIMATIONS Needs for improvement of accuracy of internal dose estimation! Needs for improvement of accuracy of internal dose estimation! Activity quantification – the main contributor! Activity quantification – the main contributor! Hybrid technology (SPECT/CT & PET/CT) allows to perform patient-specific corrections for physical (scatter, attenuation) and instrumental (PVE) phenomena improving the accuracy of activity quantification in clinical routine Hybrid technology (SPECT/CT & PET/CT) allows to perform patient-specific corrections for physical (scatter, attenuation) and instrumental (PVE) phenomena improving the accuracy of activity quantification in clinical routine Systemic Radiotherapy branch

Combined Radiotherapy (CIERT) Calderón CF | ICFA workshop | Habana, 2016 ACTIVITY QUANTIFICATION – work in progress! GOAL = standardize a clinical protocol for activity quantification from SPECT images to perform internal dose estimations in normal tissues GOAL = standardize a clinical protocol for activity quantification from SPECT images to perform internal dose estimations in normal tissues SIMIND : free code, Lund University, Sweden SIMIND : free code, Lund University, Sweden – Obtain SPECT projections by simulation using Monte Carlo techniques. – Ideal image without physical and instrument influence. It could be used as reference! – Input data: gamma camera technical data (crystal sizes, collimators, etc.) and performance characteristic (energy resolution, spatial resolution, etc.) TASKS: Evaluating different activity quantification protocols (acquisition parameters, reconstruction algorithms and post-processing, physical and instrumental corrections) using simulated and acquired images TASKS: Evaluating different activity quantification protocols (acquisition parameters, reconstruction algorithms and post-processing, physical and instrumental corrections) using simulated and acquired images Systemic Radiotherapy branch

Combined Radiotherapy (CIERT) Sequential CIERT (sCIERT) Concurrent CIERT (cCIERT) [n sMRT, A inj PS]! [n eLRT, DPS]! TWO MODALITIES COULD BE EXPLORED IN CLINICAL APPLICATIONS! Calderón CF | ICFA workshop | Habana, 2016

Linear-quadratic (LQ) model  There are some clinical experiences in both modalities (increasing!)  Simplicity, few parameters! + Partial effects are additive!  iso-effect = Biological equivalence for different irradiation schemes  Easily adjustable to different tissues (acute or late response). B iologically E ffective D ose = BED where: Calderón CF | ICFA workshop | Habana, 2016

Combined Radiotherapy (CIERT) LQ model - SOME RESULTS SEQUENTIAL (sCIERT): CONCURRENT (cCIERT): ALFIM, Costa Rica, 2013 Calderón CF | ICFA workshop | Habana, 2016

Combined Radiotherapy (CIERT) LQ model - Influence of BED cross  = 3Gy  = 10Gy sMRT using multiple administrations could be an option for optimization Calderón CF | ICFA workshop | Habana, 2016

Combined Radiotherapy (CIERT)  Dose distribution parameters: EUBED, SED 2Gy, etc.  Iso-effect profiles  Inter-subject variability  Irradiated volume effect in OARs Calderón CF | ICFA workshop | Habana, 2016 TCP(D) {D ijk } eLRT {D ijk } sMRT {BED ijk } CIERT LQ model NTCP (D) (BED)VH CIERT Iso-effects relationships In practice…

Combined Radiotherapy (CIERT) LQ model – TCP /NTCP Inter-subject variability & Radiosensitivity (  )  =0.35Gy -1  =0.25Gy -1 Calderón CF., et al, ALFIM, 2013

Combined Radiotherapy (CIERT) Calderón CF., et al, ALFIM, 2013 LQ model – TCP /NTCP Inter-subject variability & Tissue response (  )  =3Gy  =10Gy

Combined Radiotherapy (CIERT) The formulation could be used for biological evaluation of prescriptions and optimization in CIERT The formulation could be used for biological evaluation of prescriptions and optimization in CIERT OARs should carefully controlled in cCIERT as the administered activity is increased – prescription with multiples administration must be evaluated! OARs should carefully controlled in cCIERT as the administered activity is increased – prescription with multiples administration must be evaluated! Treatment planning and optimization are possible to be done in those cases where high conformed dose boost using systemic molecular radiotherapy may be chosen. Treatment planning and optimization are possible to be done in those cases where high conformed dose boost using systemic molecular radiotherapy may be chosen. Calderón CF | ICFA workshop | Habana, 2016 … remarks!

Trends for nearest & not to distant future Internal dose estimation: Internal dose estimation: – Clinical protocol for estimation of 3D dose distribution in OARs that could be used for biological treatment planning in sMRT – End to End verifying protocol for validating internal dose estimations Radiobiology: Radiobiology: – Formulation for inverse planning methods – Include functional information for calculating TCP (hypoxia) & NTCP – Evaluation of treatment planning based on goal functions (UTCP, f EUD ) – ior/RB Software - from Excel worksheets to a more friendly interface and integrated facilities. Coming soon! – Clinical trials – end points  radiobiological parameters! Calderón CF | ICFA workshop | Habana, 2016 IPET meeting IAEA, 2011 IDOS meeting IAEA, 2010

… Some reports González J., et al. Dose response model for targeted radionuclide therapy. World J Nucl Med 2004; 3: González J., et al. Dose response model for targeted radionuclide therapy. World J Nucl Med 2004; 3: González J., et al. Determination of radionuclides S values for any voxel size, based on three-dimensional discrete Fourier transform convolution method. World J Nucl Med 2007; 6: González J., et al. Determination of radionuclides S values for any voxel size, based on three-dimensional discrete Fourier transform convolution method. World J Nucl Med 2007; 6: Nápoles M, et al. Pre-clinical commissioning of plans with an aperture based IMRT treatment planning system. ICARO Proceeding of International Symposium, IAEA, Vienna, Austria, 2009 Nápoles M, et al. Pre-clinical commissioning of plans with an aperture based IMRT treatment planning system. ICARO Proceeding of International Symposium, IAEA, Vienna, Austria, 2009 C. Calderón, et al. “Validating activity prescription schemes in radionuclide therapy based on TCP and NTCP indexes calculation”. IDOS Proceeding of International Symposium, IAEA, Vienna, Austria, 2010 C. Calderón, et al. “Validating activity prescription schemes in radionuclide therapy based on TCP and NTCP indexes calculation”. IDOS Proceeding of International Symposium, IAEA, Vienna, Austria, 2010 Calderón Marín CF, et al. Using the hypoxia volume distribution for calculation of Tumor Control Probability (TCP) IPET Proceeding of International Symposium, IAEA, Vienna, Austria, 2011Calderón Marín CF, et al. Basis for the biological evaluation of treatment combining irradiation at high and low dose rate using the linear-quadratic model. World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 2012 Calderón Marín CF, et al. Using the hypoxia volume distribution for calculation of Tumor Control Probability (TCP) IPET Proceeding of International Symposium, IAEA, Vienna, Austria, 2011Calderón Marín CF, et al. Basis for the biological evaluation of treatment combining irradiation at high and low dose rate using the linear-quadratic model. World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 2012 Cancino JL, et al. Construction and dosimetrical evaluation of a beta particles irradiator designed to study the cellular response to irradiation at low dose rate. World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 2012 Cancino JL, et al. Construction and dosimetrical evaluation of a beta particles irradiator designed to study the cellular response to irradiation at low dose rate. World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 2012 Calderón CF | ICFA workshop | Habana, 2016

MUCHAS GRACIAS! | THANKS A LOT! MUCHAS GRACIAS! | THANKS A LOT! Physics and Applications of High Brightness Beams March 28-April 1, 2016 in Havana, Cuba